| Compassus - Greater Ohio 837 Crocker Road, Westlake, OH, 44145 | |
| (440) 899-7659 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is expressing deep concerns about the quality of patient care at The Ottawa Hospital following word that the facility is cutting approximately 300,000 hours of RN care per year.
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) – a form of radiation that is about three times more powerful than typical photon radiotherapy – is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are being formally presented Monday, Nov. 1, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the year ended December 31, 2011.
› Verified 8 days ago
| Name | Compassus - Greater Ohio |
|---|---|
| Location | 837 Crocker Road, Westlake, Ohio |
| Hospice ID | 361598 |
| Category | Part of a Skilled Nursing Facility |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 170 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is expressing deep concerns about the quality of patient care at The Ottawa Hospital following word that the facility is cutting approximately 300,000 hours of RN care per year.
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) – a form of radiation that is about three times more powerful than typical photon radiotherapy – is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are being formally presented Monday, Nov. 1, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the year ended December 31, 2011.
› Verified 8 days ago
| NPI Number | 1134471915 |
| Organization Name | Life Choice Hospice Of Ohio Llc |
| Address | 6000 Lombardo Ctr Ste 140 Seven Hills, Ohio, 44131 |
| Phone Number | (440)899-7659 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is expressing deep concerns about the quality of patient care at The Ottawa Hospital following word that the facility is cutting approximately 300,000 hours of RN care per year.
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) – a form of radiation that is about three times more powerful than typical photon radiotherapy – is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are being formally presented Monday, Nov. 1, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the year ended December 31, 2011.
› Verified 8 days ago
| NPI Number | 1659885135 |
| Organization Name | Nivalis Health Llc |
| Address | 837 Crocker Rd Westlake, Ohio, 44145 |
| Phone Number | (440)462-2600 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is expressing deep concerns about the quality of patient care at The Ottawa Hospital following word that the facility is cutting approximately 300,000 hours of RN care per year.
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) – a form of radiation that is about three times more powerful than typical photon radiotherapy – is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are being formally presented Monday, Nov. 1, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the year ended December 31, 2011.
› Verified 8 days ago
| NPI Number | 1750340428 |
| Organization Name | Solamor Hospice Corporation |
| Address | 837 Crocker Rd Westlake, Ohio, 44145 |
| Phone Number | (440)899-7659 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is expressing deep concerns about the quality of patient care at The Ottawa Hospital following word that the facility is cutting approximately 300,000 hours of RN care per year.
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) – a form of radiation that is about three times more powerful than typical photon radiotherapy – is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are being formally presented Monday, Nov. 1, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the year ended December 31, 2011.
› Verified 8 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 97.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 68.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 94.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 50.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 85.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 80.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 89.3 | 93.3 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is expressing deep concerns about the quality of patient care at The Ottawa Hospital following word that the facility is cutting approximately 300,000 hours of RN care per year.
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) – a form of radiation that is about three times more powerful than typical photon radiotherapy – is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are being formally presented Monday, Nov. 1, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the year ended December 31, 2011.
› Verified 8 days ago
| Counselors | 2 |
| Licensed Practical or Vocational Nurses | 6 |
| Medical Social Workers | 3 |
| Physicians | 1 |
| Registered Nurses | 4 |
| Other Personnel | 1 |
| Total Employees | 17 |
|---|
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is expressing deep concerns about the quality of patient care at The Ottawa Hospital following word that the facility is cutting approximately 300,000 hours of RN care per year.
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit are presenting two research studies that found the use of Fast Neutron Radiotherapy (FNRT) – a form of radiation that is about three times more powerful than typical photon radiotherapy – is highly effective and safe for patients who are dealing with non-small cell lung cancer. The findings are being formally presented Monday, Nov. 1, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the year ended December 31, 2011.
› Verified 8 days ago
| Compassus - Greater Ohio Location: 837 Crocker Road, Westlake, Ohio, 44145 Phone: (440) 899-7659 |
| Brookdale Hospice Cleveland Location: 24500 Center Ridge Rd, King James Bldg #4, Ste 360, Westlake, Ohio, 44145 Phone: (440) 899-7659 |
| Pathways Hospice Llc Location: 24803 Detroit Road Suite D, Westlake, Ohio, 44145 Phone: (440) 899-7659 |